Navigation Links
Patient-Specific Stem Cell Therapy to Halt or Reverse the Damage of Parkinson’s Disease Gets Support from National Stem Cell Foundation
Date:4/29/2016

Summit for Stem Cell has received a $250,000 grant from the National Stem Cell Foundation (NSCF) to support the development of a patient-specific stem cell therapy for the treatment of Parkinson’s disease. The Summit research project is directed by Dr. Andrés Bratt-Leal in the lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, CA.

The aim of of the research is to use a patient’s own skin cells to create normal dopamine-producing neurons that can be returned to the patient without rejection. Dopamine, a chemical that sends messages to areas of the brain that control movement and coordination, is decreased in Parkinson’s when dopamine-producing neurons malfunction or die. This patient-specific therapy has the potential to halt or reverse the damage of Parkinson’s disease and other neurological disorders, including ALS.

According to Dr. Paula Grisanti, National Stem Cell Foundation Chairman, “As an organization, we are committed to partnering with strong organizations and building consortiums to get great research through the funding “valley of death” that is too often the fate of promising ideas. We are delighted to make this grant for patient-specific stem cell research that will advance treatment options for Parkinson’s and other neurodegenerative diseases.”

Jenifer Raub, Summit’s Board President, says, “The generous support provided by the National Stem Cell Foundation will advance this research at a critical point and move us closer to FDA-approved clinical trials. We are thrilled by this unique partnership with NSCF.”

About Summit for Stem Cell
Summit for Stem Cell is an all-volunteer organization working to fund research that will directly impact treatment options for the debilitating effects of Parkinson's disease. Summit is at the vanguard of a unique collaboration between patients, clinicians, scientists, volunteers, patient advocates and the community-at-large to move innovative research forward in cooperation with The Scripps Research Institute and Scripps Clinic. For more information visit: http://www.SummitforStemCell.org

About National Stem Cell Foundation
The National Stem Cell Foundation is a 501(c)3 non-profit organization funding stem cell and regenerative medicine research and clinical trials in four primary focus areas: Neurodegenerative Disease, Autoimmune Disease, Rare Childhood Disorders and Regenerative Repair. NSCF’s goal is to fund promising developments in the field of regenerative medicine, support research collaboration wherever possible and accelerate access to scientific breakthroughs for people in need. For more information visit: http://www.NationalStemCellFoundation.org

Read the full story at http://www.prweb.com/releases/2016/04/prweb13376046.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. New Hudsonville-Based Biomedical Startup, Imago Prints, Uses Patient-Specific Ultrasound Data to Produce One-of-a-Kind 3D Printed Renderings of Infants During Pregnancy
2. Seamless gene correction of beta-thalassemia mutations in patient-specific cells
3. University Of Colorado Cancer Center Tests Promising New Drug to Treat and Protect Against Radiotherapy-Associated Oral Mucositis
4. Transplanted brain cells in monkeys light up personalized therapy
5. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
6. SoundMindz TM Releases ‘Anti-Anxiety TM’ Mobile App - A Complete Stress Therapy Program
7. Cellular Therapy and Cord Blood 2013 Market Report
8. Gene therapy may aid failing hearts
9. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
10. Arctic Animal, Warm Hearts: National Robotics Week Display Features Robot Therapy for Palliative and Dementia Care
11. Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation Phase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/13/2018)... ... 2018 , ... AseptiScope(TM), Inc. announces it is advancing its ... last week, confirm pose a significant health risk. The two large clinical ... are often improperly or rarely disinfected. In the AJIC November 6 issue, investigators ...
(Date:11/11/2018)... ... November 09, 2018 , ... Triple W, an innovator of connected health ... Honoree for DFree ®, the first health tech wearable device for incontinence ... go to the bathroom. The announcement was made during CES Unveiled New York, an ...
(Date:11/7/2018)... ... 2018 , ... Diversified Technologies, Inc. (DTI) has installed a PEF ... Algae Technology and Innovation at ASU. Funded by a USDA NIFA SBIR, the purpose ... algal and predator control applications. , Algae ponds get up to 50% consumed by ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed ... Like (TAL) effector code technology for applications in advancing research in epigenetic technology. ... plants. Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting has ...
Breaking Biology Technology:
(Date:12/5/2018)... ... December 04, 2018 , ... ... the much-anticipated launch of their 100-liter (26 gallon) SAFEthread Drum. The 100-liter ... in 2017, which brought a much-needed modern redesign to the plastic drums being ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... with the intention of acquiring full ownership. The transaction was approved by the ... on November 14, 2018. “We are extremely pleased to team up with Tosoh ...
(Date:11/27/2018)... CLEVELEYS, U.K. (PRWEB) , ... November 27, 2018 ... ... to offer the cryogenics industry a sealing solution with a broader range of ... November) the No-1 PEEK expert will introduce its new VICTREX CT™ 200 for ...
Breaking Biology News(10 mins):